Dot blot using ab12297 on phospho and non-phospho peptides corresponding to the immunising peptide sequence.Dots 1: 1ng of peptideDots 2: 10ng of peptideDots 3: 100ng of peptide
Lanes 1 - 2 : Anti-p95 NBS1 (phospho S432) antibody (ab12297)Lanes 3 - 4 : NBS1 antibody (recognizes modified and unmodified NBS1)Lane 1 : IP'd lysate from cells transfected with wild type (WT) NBS1.Lane 2 : IP'd lysate from cells transfected with mutant (S432A) NBS1.Lane 3 : IP'd lysate from cells transfected with wild type (WT) NBS1.Lane 4 : IP'd lysate from cells transfected with mutant (S432A) NBS1.Performed under reducing conditions.
All lanes : Anti-p95 NBS1 (phospho S432) antibody (ab12297)Lane 1 : ILB1 cells transfected with empty vector.Lane 2 : ILB1 cells transfected with wild type NBS1.Lane 3 : ILB1 cells transfected with mutant (S432A) NBS1.Performed under reducing conditions.
Anti-p95 NBS1 (phospho S432) antibody (ab12297) at 1 µg/ml + HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µgSecondaryAnti-Rabbit IgG VHH Single Domain Antibody (HRP) (ab191866) at 1/50000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.